Conagen innovates novel natural-source retinol for cosmetic formulations
22 août 2023 04h00 HE
|
Conagen
Bedford, Mass., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Conagen, the bioplatform innovator and biomanufacturer, has developed a first-of-its-kind, natural-sourced class of sustainable retinol derivative...
Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials
01 août 2023 04h00 HE
|
Conagen
Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan's leading chemical company, have announced to jointly develop...
Conagen develops debondable adhesive for textiles and soft materials from natural bioingredients
11 juil. 2023 04h01 HE
|
Conagen
Bedford, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- When more than 92 million tons of textile waste are landfilled annually, new solutions are needed to enable fabric reworking in manufacturing and...
Conagen starts first commercial production of sustainable Tyrian purple for textile dye
09 janv. 2023 03h30 HE
|
Conagen
Bedford, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Conagen announced the successful scale-up of its sustainable, cost-effective Tyrian purple, a historically coveted and expensive dye found in rare...
Conagen develops high-purity non-GMO sulforaphane by bioconversion
29 nov. 2022 15h23 HE
|
Conagen
Bedford, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Expanding on its portfolio of innovative nutritional products through biotechnology, Conagen, announced the development of its 99% high-purity...
Conagen’s fermentation platform expands on promising novel forms of vitamin K2
31 oct. 2022 05h38 HE
|
Conagen
Bedford, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Biotech innovator, Conagen announced the development of its fermentation-derived vitamin K2 - a high-purity all-trans menaquinone-7 (MK-7). This is...
Conagen unveils commercial production of high-purity non-GMO salidroside
27 sept. 2022 04h00 HE
|
Conagen
Bedford, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Conagen announced the commercialization of its 99% high-purity salidroside made by bioconversion technology, an active ingredient from the herbal...
Conagen commercializes scalable sweetness enhancers from nature
08 juil. 2022 04h33 HE
|
Conagen
Bedford, Mass., July 08, 2022 (GLOBE NEWSWIRE) -- Conagen, the Massachusetts-based biotech firm, announced the commercialization of an expansive portfolio of natural sweetness enhancers for taste...
Conagen’s New Dihydro Resveratrol Made By Clean Bioconversion Inspires Novel Products and Drives Market Growth
31 mai 2022 05h01 HE
|
Conagen
Bedford, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- Massachusetts-based biotech Conagen announces the development of a new scalable natural compound, dihydro resveratrol, for use in industrial and...
Conagen’s Grant Award Opens New Markets for Monoclonal Antibodies
29 mars 2022 05h10 HE
|
Conagen
Bedford, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- The Bill & Melinda Gates Foundation has given a grant to Conagen to support further development of its Conamax(TM) platform for the production...